In vivo pharmacology of aprosulate, a new synthetic polyanion with anticoagulant activity
- 1 January 1993
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 69 (1), 71-80
- https://doi.org/10.1016/0049-3848(93)90004-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082European Journal of Biochemistry, 1992
- Interaction of the sulfated lactobionic acid amide LW 10082 with thrombin and its endogenous inhibitorsThrombosis Research, 1991
- Anticoagulant and antithrombotic properties of synthetic sulfated bis-lactobionic acid amidesThrombosis Research, 1989
- Studies on antithrombotic effects of recombinant hirudinThrombosis Research, 1989
- Heparin therapy for venous thrombosis and pulmonary embolismBlood Reviews, 1988
- Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.Stroke, 1986
- FIBRIN, RED CELL AND PLATELET INTERACTIONS IN AN EXPERIMENTAL MODEL OF THROMBOSISBritish Journal of Pharmacology, 1982
- A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trialBritish Journal of Surgery, 1979
- Bleeding time in laboratory animals. II - A comparison of different assay conditions in ratsThrombosis Research, 1979
- HÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPYThe Lancet, 1977